| Daniel S Hoffman, MD | |
|
270 Northlake Blvd Ste 1008, Altamonte Springs, FL 32701-4335 | |
| (407) 834-3300 | |
| (407) 834-3800 |
| Full Name | Daniel S Hoffman |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 15 Years |
| Location | 270 Northlake Blvd Ste 1008, Altamonte Springs, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881823227 | NPI | - | NPPES |
| TJ3E3 | Other | FL | BLUECROSS BLUE SHIELD |
| 021654700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME133096 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Medical Group Inc | 0749186153 | 1163 |
News Archive
Switching a university dining hall from a system using trays to a trayless system significantly reduces the amount of food waste produced per patron, say researchers.
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that preclinical data on three of its pipeline candidates will be highlighted at the XXIII International Complement Workshop taking place August 1-5, 2010, in New York City.
If more women quit smoking before they became pregnant, it would save infant lives, concludes a new study from the Centers for Disease Control and Prevention (CDC).
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.
› Verified 2 days ago
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
Switching a university dining hall from a system using trays to a trayless system significantly reduces the amount of food waste produced per patron, say researchers.
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that preclinical data on three of its pipeline candidates will be highlighted at the XXIII International Complement Workshop taking place August 1-5, 2010, in New York City.
If more women quit smoking before they became pregnant, it would save infant lives, concludes a new study from the Centers for Disease Control and Prevention (CDC).
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel S Hoffman, MD 270 Northlake Blvd Ste 1008, Altamonte Springs, FL 32701-4335 Ph: (407) 834-3300 | Daniel S Hoffman, MD 270 Northlake Blvd Ste 1008, Altamonte Springs, FL 32701-4335 Ph: (407) 834-3300 |
News Archive
Switching a university dining hall from a system using trays to a trayless system significantly reduces the amount of food waste produced per patron, say researchers.
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that preclinical data on three of its pipeline candidates will be highlighted at the XXIII International Complement Workshop taking place August 1-5, 2010, in New York City.
If more women quit smoking before they became pregnant, it would save infant lives, concludes a new study from the Centers for Disease Control and Prevention (CDC).
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.
› Verified 2 days ago
Steve K Williams, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 270 Northlake Blvd, Suite 1008, Altamonte Springs, FL 32701 Phone: 407-834-3300 Fax: 407-834-3800 | |
Dr. Thomas G Cangiano, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 270 Northlake Blvd, Suite 1008, Altamonte Springs, FL 32701 Phone: 407-834-3300 Fax: 407-834-3800 |